{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T23:46:19Z","timestamp":1772063179910,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.leukres.2012.03.025","type":"journal-article","created":{"date-parts":[[2012,4,21]],"date-time":"2012-04-21T03:59:03Z","timestamp":1334980743000},"page":"1028-1034","source":"Crossref","is-referenced-by-count":10,"title":["Gadd45a transcriptional induction elicited by the Aurora kinase inhibitor MK-0457 in Bcr-Abl-expressing cells is driven by Oct-1 transcription factor"],"prefix":"10.1016","volume":"36","author":[{"given":"Manuela","family":"Mancini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Leo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Aluigi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Marcozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrica","family":"Borsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enza","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Alessandra","family":"Santucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2012.03.025_bib0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1750-2187-3-15","article-title":"Gadd45 in stress signaling","volume":"3","author":"Liebermann","year":"2008","journal-title":"J Mol Signal"},{"key":"10.1016\/j.leukres.2012.03.025_bib0010","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nature05515","article-title":"Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation","volume":"445","author":"Barreto","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2012.03.025_bib0015","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1038\/sj.onc.1205774","article-title":"Genomic instability, centrosome amplification, cell cycle checkpoints and Gadd45a","volume":"21","author":"Hollander","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2012.03.025_bib0020","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/13802","article-title":"Genomic instability in Gadd45a-deficient mice","volume":"23","author":"Hollander","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.leukres.2012.03.025_bib0025","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1158\/1078-0432.CCR-05-1475","article-title":"Gadd45 deregulation in cancer: frequently methylated tumor suppressors and potential therapeutic targets","volume":"11","author":"Zerbini","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2012.03.025_bib0030","doi-asserted-by":"crossref","first-page":"8448","DOI":"10.1158\/0008-5472.CAN-06-2013","article-title":"Gadd45a suppresses Ras-driven mammary tumorigenesis by activation of c-Jun NH2-terminal kinase and p38 stress signaling resulting in apoptosis and senescence","volume":"66","author":"Tront","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2012.03.025_bib0035","doi-asserted-by":"crossref","first-page":"28943","DOI":"10.1074\/jbc.M600235200","article-title":"Gadd45a interacts with Aurora-A and inhibits its kinase activity","volume":"281","author":"Shao","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2012.03.025_bib0040","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/nrc2964","article-title":"Shared and separate functions of polo-like kinases and Aurora kinases in cancer","volume":"10","author":"Lens","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.leukres.2012.03.025_bib0045","doi-asserted-by":"crossref","first-page":"6175","DOI":"10.1038\/sj.onc.1205775","article-title":"On the role of Aurora-A in centrosome function","volume":"21","author":"Dutertre","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2012.03.025_bib0050","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/leu.2010.67","article-title":"BCR\u2013ABL: a multi-faceted promoter of DNA mutation in chronic myelogenous leukemia","volume":"24","author":"Burke","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2012.03.025_bib0055","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2004-03-0849","article-title":"Activation of the PI3K\/mTOR pathway by BCR\u2013ABL contributes to increased production of reactive oxygen species","volume":"105","author":"Kim","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2012.03.025_bib0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.onc.1209756","article-title":"Fusion tyrosine kinases: a result and cause of genomic instability","volume":"26","author":"Penserga","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2012.03.025_bib0065","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/leu.2009.49","article-title":"Bcr-Abl-mediated redox regulation of the PI3K\/AKT pathway","volume":"23","author":"Naughton","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2012.03.025_bib0070","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1172\/JCI41246","article-title":"Chronic myeloid leukemia: mechanisms of blastic transformation","volume":"120","author":"Perrotti","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.leukres.2012.03.025_bib0075","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1158\/1535-7163.MCT-09-0936","article-title":"Expression of oncogenic kinase Bcr-Abl impairs mitotic checkpoint and promotes aberrant division and resistance to microtubule-targeting agents","volume":"9","author":"Wolanin","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.leukres.2012.03.025_bib0080","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/leu.2010.15","article-title":"Aurora kinase inhibitors: novel small molecules with promising activity in acute myeloid and philadelphia-positive leukemias","volume":"24","author":"Moore","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2012.03.025_bib0085","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1158\/0008-5472.CAN-05-2788","article-title":"Structure of the kinase domain of an imatinib-resistant Abl mutant in complex with the Aurora kinase inhibitor VX-680","volume":"66","author":"Young","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2012.03.025_bib0090","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1128\/MCB.22.3.874-885.2002","article-title":"Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases","volume":"22","author":"Crosio","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.leukres.2012.03.025_bib0095","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.chembiol.2008.09.014","article-title":"Expression of histone H3 tails with combinatorial lysine modifications under the reprogrammed genetic code for the investigation on epigenetic markers","volume":"15","author":"Kang","year":"2008","journal-title":"Chem Biol"},{"key":"10.1016\/j.leukres.2012.03.025_bib0100","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1038\/sj.onc.1207091","article-title":"p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y","volume":"22","author":"Hirose","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2012.03.025_bib0105","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2141.2005.05873.x","article-title":"P210 Bcr-Abl tyrosine kinase interaction with histone deacetylase 1 modifies histone H4 acetylation and chromatin structure of chronic myeloid leukaemia haematopoietic progenitors","volume":"132","author":"Brusa","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2012.03.025_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-9120(98)00092-7","article-title":"Procedure for the quantitation of Gadd45 expression levels in clonal hematopoietic progenitor cells by competitive polymerase chain reaction","volume":"32","author":"Santucci","year":"1999","journal-title":"Clin Biochem"},{"key":"10.1016\/j.leukres.2012.03.025_bib0115","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1038\/sj.onc.1203609","article-title":"Degradation of human Aurora2 protein kinase by the anaphase-promoting complex-ubiquitin-proteasome pathway","volume":"19","author":"Honda","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2012.03.025_bib0120","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/leu.2010.24","article-title":"Role of BCR-ABL-Y177 mediated p27kip1 phosphorylation and cytoplasmatic localization in enhanced proliferation of chronic myeloid leukemia","volume":"24","author":"Chu","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2012.03.025_bib0125","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1038\/sj.onc.1204390","article-title":"Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of Gadd45 following DNA damage","volume":"20","author":"Jin","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2012.03.025_bib0130","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000296275","article-title":"Histone post-translational modifications in DNA damage response","volume":"128","author":"M\u00e9ndez-Acuna","year":"2010","journal-title":"Cytogenet Genome Res"},{"key":"10.1016\/j.leukres.2012.03.025_bib0135","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.bcp.2009.10.009","article-title":"Targets and effectors of the cellular response to aurora kinase inhibitor MK-0457 (VX-680) in imatinib sensitive and resistant chronic myelogenous leukemia","volume":"79","author":"Donato","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.leukres.2012.03.025_bib0140","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1182\/blood-2006-05-025049","article-title":"MK-0457, a novel kinase inhibitor, is active in patients with chronic myeloid leukemia or acute lymphocytic leukemia with the T315I BCR-ABL mutation","volume":"109","author":"Giles","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2012.03.025_bib0145","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.leukres.2008.04.012","article-title":"PHA-680626 exhibits anti-proliferative and pro-apoptotic activity on imatinib-resistant chronic myeloid leukemia cell lines and primary CD34+ cells by inhibition of both Bcr-Abl tyrosine kinase and Aurora kinases","volume":"32","author":"Gontarewicz","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2012.03.025_bib0150","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1349-7006.2008.00810.x","article-title":"Activity of a novel Aurora kinase inhibitor against the T315I mutant form of BCR-ABL: in vitro and in vivo studies","volume":"99","author":"Akahane","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.leukres.2012.03.025_bib0155","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1182\/blood-2007-09-113175","article-title":"Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I","volume":"111","author":"Gontarewicz","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2012.03.025_bib0160","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.bbrc.2009.01.141","article-title":"Mechanisms of MK-0457 against BCR-ABL positive leukemia cells","volume":"380","author":"Okabe","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.leukres.2012.03.025_bib0165","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1111\/j.1582-4934.2010.01218.x","article-title":"The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib","volume":"15","author":"Kelly","year":"2011","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.leukres.2012.03.025_bib0170","doi-asserted-by":"crossref","first-page":"36892","DOI":"10.1074\/jbc.M005319200","article-title":"Identification of a functional domain in Gadd45-mediated G2\/M checkpoint","volume":"275","author":"Yang","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2012.03.025_bib0175","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.4161\/cc.6.22.4940","article-title":"VX-680 inhibits Aurora A and B kinase activity in human cells","volume":"6","author":"Tyler","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.leukres.2012.03.025_bib0180","doi-asserted-by":"crossref","first-page":"22196","DOI":"10.1074\/jbc.M109.069344","article-title":"Solution structure of human growth arrest and DNA damage 45\u03b1 (Gadd45\u03b1) and its interactions with proliferating cell nuclear antigen (PCNA) and Aurora A kinase","volume":"285","author":"S\u00e0nchez","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2012.03.025_bib0185","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0092-8674(92)90593-2","article-title":"A mammalian cell cycle checkpoint pathway utilizing p53 and Gadd45 is defective in ataxia-telengectasia","volume":"71","author":"Kastan","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2012.03.025_bib0190","first-page":"1187","article-title":"Involvement of the Oct-1 regulatory element of Gadd45 promoter in the p53-independent response to ultaviolet irradiation","volume":"61","author":"Takahashi","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2012.03.025_bib0195","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0092-8674(04)00044-3","article-title":"The nucleosome: from genomic organization to genomic regulation","volume":"116","author":"Khorasanizadeh","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2012.03.025_bib0200","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.4161\/cc.5.24.3540","article-title":"Dynamic regulation of effector protein binding to histone modifications: the biology of HP1 switching","volume":"5","author":"Dormann","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.leukres.2012.03.025_bib0205","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.ejca.2009.04.005","article-title":"Epigenetic down-regulation of BIM expression is associated with reduced optimal response to imatinib treatment in chronic myeloid leukemia","volume":"45","author":"San Jos\u00e9-Eneriz","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.leukres.2012.03.025_bib0210","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1038\/sj.onc.1210165","article-title":"DNA-PK phosphorylation sites in Oct-1 promote cell survival following DNA damage","volume":"26","author":"Schild-Poulter","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2012.03.025_bib0215","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1182\/blood.V97.7.2084","article-title":"BCR-ABL down-regulates the DNA repair protein DNA-PKcs","volume":"97","author":"Deutsch","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2012.03.025_bib0220","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.4161\/cc.8.10.8500","article-title":"DNA excision repair proteins and Gadd45 as molecular players for active DNA demethylation","volume":"8","author":"Ma","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.leukres.2012.03.025_bib0225","doi-asserted-by":"crossref","first-page":"13618","DOI":"10.1073\/pnas.0402069101","article-title":"NF-kappa B-mediated repression of growth arrest- and DNA-damage-inducible proteins 45alpha and gamma is essential for cancer cell survival","volume":"101","author":"Zerbini","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2012.03.025_bib0230","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.canlet.2008.01.001","article-title":"BARD1 regulates BRCA1-mediated transactivation of the p21WAF1\/CIP1 and Gadd45 promoters","volume":"18","author":"Fabbro","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.leukres.2012.03.025_bib0235","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkr638","article-title":"Myc and PI3K\/AKT signaling coperatively represses FOXO3a-dependent PUMA and Gadd45a gene expression","author":"Amente","year":"2011","journal-title":"Nucleic Acids Res"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212612001701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212612001701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T19:25:45Z","timestamp":1543001145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212612001701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0145212612001701"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2012.03.025","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}